CLDI - Calidi Biotherapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $1.2. This is a potential upside of $-0.34 (-22.08%) from yesterday's end of day stock price of $1.54.

Calidi Biotherapeutics's activity chart (see below) currently has 4 price targets and 3 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 15 days.

Most recent stock forecast was given by JOEL BEATTY from BAIRD on 15-May-2024. First documented stock forecast 09-Oct-2023.

Best performing analysts who are covering CLDI - Calidi Biotherapeutics:

Joel Beatty

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$2

$0.46 (29.87%)

$4.5

1 years 5 months 10 days ago
(15-May-2024)

2/2 (100%)

$-0.34 (-14.53%)

15

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CLDI (Calidi Biotherapeutics) average time for price targets to be met?

On average it took 15 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on CLDI (Calidi Biotherapeutics) with a proven track record?

JOEL BEATTY

Which analyst has the most public recommendations on CLDI (Calidi Biotherapeutics)?

Joel Beatty works at BAIRD and has 4 price targets and 3 ratings on CLDI

Which analyst is the currently most bullish on CLDI (Calidi Biotherapeutics)?

Joel Beatty with highest potential upside - $0.46

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?